Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • UK faces first national train drivers’ strike in 25 years
    • Crypto collapse reverberates widely among black American investors
    • My garlic for a home: China struggles to revive property sector
    • Six dead after gunman attacks July 4 holiday parade in Chicago suburb
    • Germany draws up law to take stakes in struggling gas importers
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Crypto collapse reverberates widely among black American investors
    • How the man behind the Apple Store presided over a Spac catastrophe
    • Michael Lewis: ‘The thing that really works for Trump is: the system’s rigged’
    • Six dead after gunman attacks July 4 holiday parade in Chicago suburb
    • Why groupthink might be a good thing after all
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • EY boosts accountancy title inflation by dubbing senior staff ‘partner’
    • KPMG’s business in UAE split by partner infighting and coup attempt
    • How the man behind the Apple Store presided over a Spac catastrophe
    • China’s Warren Buffett-backed BYD overtakes Tesla in global EV sales
    • First female chair of Herbert Smith Freehills says flexible working made role attractive
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Live news updates: Europe gas flows under renewed pressure after Norway’s Equinor hit by strike
    • Foreign investors dump record $33bn of Indian stocks since October
    • Bundesbank boss warns against ‘fatal’ assumptions in ECB crisis tool
    • Emerging markets are in better shape than you think
    • Liquidity strains in markets need structural fixes
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Erdoğan is an infuriating but indispensable ally
    • Why groupthink might be a good thing after all
    • What to wear to the office when it’s too hot to wear anything
    • Overturning Roe will deny women life-saving treatment for late miscarriages like my own
    • Companies should follow through on pledges to leave Russia
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Michael Lewis: ‘The thing that really works for Trump is: the system’s rigged’
    • Meet the founders with the boomerang factor
    • British Rail: A New History — a timely reminder of how to run a railway
    • Pop-up leaders and flexible staff are ready for a new crisis
    • How can I move from being a specialist police detective to financial services?
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • What to wear to the office when it’s too hot to wear anything
    • Swimsuits to make a splash in 
    • Rule, Nostalgia — a sharp new history of longing for the good old days
    • To catch a rare-book thief
    • Should you brave fuel queues and blackouts to keep holidaying in Sri Lanka?
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Health Care

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Monday, 4 July, 2022
    Amy Kazmin
    Overturning Roe will deny women life-saving treatment for late miscarriages like my own

    Campaigners in the US and Malta are protesting against laws that prevent doctors inducing abortion even in dangerous circumstances

  • Friday, 1 July, 2022
    Lex
    Walgreens: without a sale of Boots, US group needs a health check Premium content

    Owning physical drugstores is not the cash cow it once was

  • Tuesday, 28 June, 2022
    Reproductive rights
    Abortion pills in demand after reversal of Roe vs Wade

    Remote providers report a leap in requests as conservative US states roll out a number of restrictions

  • Monday, 27 June, 2022
    Covid-19 vaccines
    Pause in medication would improve Covid jab response for millions, study shows

    Short break in immune suppression treatment improves antibody production after vaccination while doing little harm

  • Monday, 27 June, 2022
    CareTech Holdings PLC
    CareTech to be taken private by founders in £1.2bn deal

    UK social care provider has benefited from rising demand during the pandemic

  • Thursday, 23 June, 2022
    Coronavirus treatment
    UK prepares to include over-50s in autumn Covid booster campaign

    Javid says he asked officials to revise previous plans that would exclude under-65s

  • Wednesday, 15 June, 2022
    Covid-19 vaccines
    FDA advisory panel backs Covid-19 vaccines for children under 5

    US prepares to roll out jabs to last age group without access once regulatory approval is received

  • Monday, 13 June, 2022
    Stephen Bush
    Care homes have a problem — they are focusing on the wrong customer

    The ‘testimonials’ page of many facilities is long on statements from relatives, but not from those in care themselves

  • Sunday, 12 June, 2022
    Mental health
    Mental ill health drives worklessness among UK young men, research finds

    Charities warn trend could lead to ‘vicious cycle’ barring many aged 18-24 from workforce

  • Thursday, 9 June, 2022
    Mediclinic International PLC
    Mediclinic rejects £3.4bn takeover proposal

    Private hospitals group says offer from shipping group and its biggest shareholder undervalues company

  • Tuesday, 7 June, 2022
    Covid-19 vaccines
    FDA panel backs Novavax Covid jab with hopes of persuading sceptics

    Protein-based vaccine is an alternative to mRNA technology used by BioNTech/Pfizer and Moderna

  • Friday, 3 June, 2022
    John Burn-Murdoch
    How to fix Britain’s chronically ill healthcare system

    The NHS needs long-term investment to build capacity and a shift in the balance away from hospital treatment

  • Thursday, 2 June, 2022
    The Big Read
    Covid, burnout and low pay: the global crisis in nursing

    Nurses were lauded as ‘heroes’ by governments when the pandemic hit, but dismal working conditions have led many to quit the profession

  • Thursday, 26 May, 2022
    Special ReportFT Health Centre
    FT Health: Future of Antibiotics

    The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain

  • Thursday, 26 May, 2022
    Special ReportFT Health: Future of Antibiotics
    Vaccines hold potential to curb antibiotic resistance

    Prevention is better than cure — but is too costly for some countries where drug-resistant bacteria are rampant

  • Thursday, 26 May, 2022
    Special ReportFT Health: Future of Antibiotics
    Diagnostic tests a crucial tool in fight against antibiotic resistance

    Identifying conditions can prevent inappropriate drug use, but there are barriers to progress in poorer regions

  • Tuesday, 24 May, 2022
    Special purpose acquisition companies
    Shares in second-largest Spac target sink by half in trading debut

    Healthcare litigation group MSP Recovery had claimed a $33bn valuation despite losses

  • Tuesday, 24 May, 2022
    Coronavirus pandemic
    Women twice as likely to suffer from long Covid, study suggests

    People with a history of autoimmune disease or depression were also more likely to have the condition

  • Tuesday, 24 May, 2022
    ExplainerDisease control and prevention
    Monkeypox: what to know about the latest virus sparking alarm

    Officials are reacting to the largest outbreak outside sub-Saharan Africa

  • Sunday, 22 May, 2022
    Jennifer Dixon
    Ministers should be wary of declaring war on the NHS

    Health service problems stemming from political choices are not an argument for a radical overhaul

  • Friday, 20 May, 2022
    Camilla Cavendish
    The NHS needs access to our shared medical data to save lives

    Public debate has been riddled with confusing claims, technical incompetence and vested interests

  • Wednesday, 18 May, 2022
    Coronavirus pandemic
    How can Covid-19 affect the human brain?

    Scientists are trying to understand the cause of neurological effects and whether symptoms will be long-lasting

  • Sunday, 1 May, 2022
    The Big Read
    Mental health and the pandemic: the growing crisis facing children

    Underfunding of some services and pent-up demand caused by lockdowns means some young people are waiting months for help

  • Thursday, 28 April, 2022
    Data PointsJohn Burn-Murdoch
    UK healthcare is already being privatised, but not in the way you think

    The creeping Americanisation of British medical bills reflects the strains on the NHS

  • Tuesday, 26 April, 2022
    Special Report
    FT Health: Innovation in Healthcare

    The final instalment of our series on innovation in European healthcare examines the effects of the slump in biotech valuations and changes in EU health policy

Previous page You are on page 1 Next page

Topics related to Health & pharmaceuticals

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In